Mexican Population Threatened By Diabetes - What Are The Major Challenges?

Main Category: Diabetes
Article Date: 21 Jun 2008 - 8:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:3 stars

3 (1 votes)

Healthcare Prof:2 stars

2 (1 votes)


Frost & Sullivan will host a live briefing on Wednesday, June 25, at 3:00pm EDT to provide industry participants an overview of a recently published study focusing on the Diabetes Market in Mexico.

Currently, there are more than 10 million diabetics, from which only 20% is following a correct treatment, in Mexico. Population growth and aging are two of the factors that keep increasing the potential for this market. New brands and products have already been introduced into this market so far, splitting the diabetes therapy business in three segments: insulin, anti diabetes drugs and self monitoring accessories. Therefore, pharmaceutical companies face a tough competitive environment to gain public and private healthcare sectors' share. Highlights of the briefing include: main drivers and restraints, as well as the major challenges that both, public and private sectors, will confront.

This briefing is based upon ongoing Healthcare industry analysis and it will benefit everyone involved in the diabetes market: companies which provide any diabetes therapy products, as well as public and private healthcare institutions.

"The diabetes market growth in Mexico is starting to impact on the structure and functioning of the healthcare system. Not only the public healthcare sector, but also the diabetes therapy providers will confront major challenges. However, good opportunities for suppliers will arise as long as they can deal with the competitive environment," reveals María Clark, Research Analyst for Frost & Sullivan.

Frost & Sullivan will hold this live briefing at 2pm CDT / 3:00pm EDT on Wednesday, June 25, 2008, which will provide industry participants an outlook on the Diabetes Market in Mexico. To participate, please e-mail José María Jantus at jjantus_pr@frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. Upon receipt of the above information, a registration link will be e-mailed to you.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

Frost & Sullivan

Article adapted by Medical News Today from original press release.
Visit our diabetes section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Frost & Sullivan. "Mexican Population Threatened By Diabetes - What Are The Major Challenges?." Medical News Today. MediLexicon, Intl., 21 Jun. 2008. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/112263.php>

APA
Frost & Sullivan. (2008, June 21). "Mexican Population Threatened By Diabetes - What Are The Major Challenges?." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/112263.php.

Please note: If no author information is provided, the source is cited instead.


Diabetes

What is Diabetes?

Diabetes (diabetes mellitus) is classed as a metabolism disorder. Metabolism refers to the way our bodies use digested food for energy and growth. Most of what we eat is broken down into glucose. Glucose is a form of sugar in the blood... Read more...

Most Popular Articles



Follow Our Diabetes News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Diabetes Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »